Alector to present at stifel's 3rd annual cns day

South san francisco, calif., march 25, 2021 (globe newswire) -- alector, inc. (nasdaq: alec), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that shehnaaz suliman, m.d., mba, m.phil., president and chief operating officer of alector, will participate in a fireside chat at stifel's 3rd annual cns day on thursday, april 1, 2021, at 9:30 a.m. et.

ALEC Ratings Summary

ALEC Quant Ranking